G
ISSUER//CIK 0000772320
Gene Biotherapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A75.7 KBGene Biotherapeutics, Inc.Feb 3, 10:44 AM ET·0001493152-23-003486
- 10-K/A4.6 MBGene Biotherapeutics, Inc.Apr 13, 7:44 PM ET·0001493152-22-009863
- 10-K4.6 MBGene Biotherapeutics, Inc.Mar 30, 5:22 PM ET·0001493152-22-008205
- SC 13G/A13.4 KBGene Biotherapeutics, Inc.Jan 4, 9:23 PM ET·0001535610-22-000040
- 10-Q3.3 MBGene Biotherapeutics, Inc.Oct 27, 9:16 AM ET·0001493152-21-026416
- 10-Q2.9 MBGene Biotherapeutics, Inc.Sep 17, 4:17 PM ET·0001493152-21-023014
- 10-Q3.0 MBGene Biotherapeutics, Inc.Sep 3, 2:52 PM ET·0001493152-21-021992
- 8-K/A50.9 KBGene Biotherapeutics, Inc.Aug 9, 4:58 PM ET·0001493152-21-019050
- 8-K34.2 KBGene Biotherapeutics, Inc.Aug 5, 4:22 PM ET·0001493152-21-018727
- 8-K54.0 KBGene Biotherapeutics, Inc.Jul 28, 5:00 PM ET·0001493152-21-017997
Insiders
10- Gabrielson Edward WDirector
- Grainer James LDirector, Chairman of the Board & CFO
- HUTCHISON MURRAY HDirector
- Jemapete Christopher J10% Owner
- Leitch Andrew MDirector
- Moreadith RandallFormer Exec. VP and CMO
- MULROY DENNISChief Financial Officer
- MULYE NIRMAL10% Owner
- Nostrum Pharmaceuticals, LLC10% Owner
- Otremba Lon EDirector
Tickers
No tickers on record
Addresses
business
11750 SORRENTO VALLEY ROAD SUITE 250
SAN DIEGO, CA, 92121
mailing
11750 SORRENTO VALLEY ROAD SUITE 250
SAN DIEGO, CA, 92121
Former Names
- Taxus Cardium Pharmaceuticals Group Inc.2018-09-13
- Cardium Therapeutics, Inc.2014-03-04
- ARIES VENTURES INC2006-01-06
- CASMYN CORP2000-05-09